574 related articles for article (PubMed ID: 20150258)
1. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.
Willmann JK; Kimura RH; Deshpande N; Lutz AM; Cochran JR; Gambhir SS
J Nucl Med; 2010 Mar; 51(3):433-40. PubMed ID: 20150258
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
[TBL] [Abstract][Full Text] [Related]
5. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
6. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
Jun HY; Park SH; Kim HS; Yoon KH
Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
[TBL] [Abstract][Full Text] [Related]
7. Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles.
Pathak V; Nolte T; Rama E; Rix A; Dadfar SM; Paefgen V; Banala S; Buhl EM; Weiler M; Schulz V; Lammers T; Kiessling F
Biomaterials; 2021 Aug; 275():120896. PubMed ID: 34090049
[TBL] [Abstract][Full Text] [Related]
8. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound].
Hu GQ; Yang L; Xiao YB; Xie JJ; Wu JF; Cai JJ; Liu J; Liao WJ; Bin JP
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):655-8. PubMed ID: 21122377
[TBL] [Abstract][Full Text] [Related]
10. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
[TBL] [Abstract][Full Text] [Related]
11. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
12. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins.
Leong-Poi H; Christiansen J; Klibanov AL; Kaul S; Lindner JR
Circulation; 2003 Jan; 107(3):455-60. PubMed ID: 12551871
[TBL] [Abstract][Full Text] [Related]
14. Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
Moore SJ; Hayden Gephart MG; Bergen JM; Su YS; Rayburn H; Scott MP; Cochran JR
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14598-603. PubMed ID: 23950221
[TBL] [Abstract][Full Text] [Related]
15. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.
Kimura RH; Cheng Z; Gambhir SS; Cochran JR
Cancer Res; 2009 Mar; 69(6):2435-42. PubMed ID: 19276378
[TBL] [Abstract][Full Text] [Related]
16. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.
Kimura RH; Levin AM; Cochran FV; Cochran JR
Proteins; 2009 Nov; 77(2):359-69. PubMed ID: 19452550
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z
J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
